New hope for migraine

Know about a new drug & if it is for you

- Dr PN Renjen

MIGRAINE CAN BE debilitating. However, a new drug, atogepant, which is taken orally, promises efficacy for the condition. But how effective is it? Dr PN Renjen, senior consultant, neurology, Indraprastha Apollo Hospitals, says: "Atogepant is a promising oral medication for the preventive treatment of migraines. It is a calcitonin gene-related peptide (CGRP) receptor antagonist, specifically designed to reduce the frequency of migraine days. Clinical trials, such as the advance and elevate studies, demonstrated significant efficacy in reducing monthly migraine days (MMDs) and improving functional outcomes within just weeks of treatment. In particular, atogepant showed early benefits, with reductions in weekly migraine days and improved quality-of-life measures during the first month of use. It is effective for both episodic and chronic migraines